A prospective, randomised, partially-blinded, placebo-controlled, phase III, multicentre trial to assess safety, tolerability and imunogenicity of liquid influenza virus vaccine, trivalent, types A & B, live cold-adapted (liquid CAIV-T) administered concomitantly with live, attenuated, poliovirus vaccine in healthy children
Download
Adobe PDF
(1.95 MB)